Pharmacotherapy for Body Dysmorphic Disorder

摘要

Serotonin-reuptake inhibitors (SRIs or SSRIs) and cognitive behavioral therapy (CBT) are currently considered the first-line treatments for body dysmorphic disorder (BDD). A practice guideline and a Cochrane review that recommend these treatments have been published, although treatment research on BDD is still quite limited. The publication of these landmark documents underscores how important it is for clinicians to be knowledgeable about current treatment recommendations for BDD